Recall
FDAHealthMarch 11, 2025

Glenmark Pharmaceuticals Inc., USA — chlorproMAZINE Hydrochloride Tablets, USP 100 mg, Rx Only, 100 Tablets per bottle, Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430, Product

⚠️ CGMP deviations: presence of N-Nitroso-Desmethyl Chlorpromazine impurity above the recommended interim limit.

Is this relevant to me?

Geography
Nationwide
Source agency
FDA
Category
Health
Published
March 11, 2025

Nationwide in the USA and PR

What's affected?

Product
chlorproMAZINE Hydrochloride Tablets, USP 100 mg, Rx Only, 100 Tablets per bottle, Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430, Product of India, NDC 68462-864-01
UPC
0368462862018
Lot code
17232222

Additional details

Lot#s: 17232222 and 17232237, Exp 10/31/2025

What should I do?

Recommended action

Class II recall. Voluntary: Firm initiated Quantity affected: 8160 bottles.

View original FDA notice →

Get Health recall alerts

Delivered to your inbox. Free. No account required.